for people ages 18-65 (full criteria)
at La Jolla, California
study started
estimated completion
Principal Investigator
by Dawn Eichen, PhD



Currently, the best behavioral treatments for obesity only work for 50% of adults, and of those who initially succeed, most do not maintain their weight loss. One reason for this failure may be due to neurocognitive deficits found among individuals with obesity, particularly related to executive function, which make it difficult for these adults to adhere to treatment recommendations. The proposed study aims to develop a Novel Executive Function Treatment (NEXT), which when administered prior to the behavioral treatment, could help improve outcomes by addressing the neurocognitive deficits in adults with overweight or obesity.


First, to assist with treatment development, two groups of approximately 10 participants will be enrolled in a 12-week open-label treatment group of NEXT. These participants will then provide qualitative feedback to help with treatment development. After the two pilot groups, a randomized control trial will evaluate NEXT compared to standard BWL to assess feasibility, acceptability and preliminary efficacy. Treatment will be 6 months long and assessments will occur at baseline, mid-treatment, post-treatment and 6-months after treatment.


Overweight and Obesity, weight loss, executive function, Obesity, Overweight, Behavioral Weight Loss - BWL, Novel Executive Function Training - NEXT


You can join if…

Open to people ages 18-65

  • Age 18-65
  • Ability to read English at a 6th grade level
  • BMI >25 and ≤45
  • Difficulties with executive functioning

You CAN'T join if...

  • Medical condition that requires physician monitoring to participate in weight control program or prohibits safely participating in recommended physical activity
  • Psychiatric condition that could interfere with program participant (e.g., substance abuse, suicide attempt within previous 6 months, active purging)
  • Currently pregnant, lactating or plan to be in the timespan of program follow-up
  • Current enrollment in an organized weight control program
  • Change in psychotropic medication or other medication that could have impact on weight during the previous 3 months
  • History of bariatric surgery
  • History of learning disorder, neurological condition or injury


  • UCSD Center for Healthy Eating and Activity Research (CHEAR
    La Jolla California 92093 United States

Lead Scientist at UCSD

  • Dawn Eichen, PhD
    Assistant Adjunct Professor, Pediatrics, Vc-health Sciences-schools. Authored (or co-authored) 43 research publications


in progress, not accepting new patients
Start Date
Completion Date
University of California, San Diego
Study Type
About 67 people participating
Last Updated